Trial Profile
A real world,retrospective, observational study comparing outcomes in patients with Acute Coronary Syndrome undergoing percutaneous coronary intervention treated with Prasugrel and Ticagrelor
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions
- 06 Apr 2017 New trial record